openPR Logo
Press release

Growing Industry of Nonalcoholic Steatohepatitis Therapeutics Market - Growth and Demand Forecast to 2023

04-11-2018 08:02 AM CET | Health & Medicine

Press release from: P&S Market Research - Healthcare

Growing Industry of Nonalcoholic Steatohepatitis

The global nonalcoholic steatohepatitis (NASH) therapeutics market is expected to witness significant growth due to current unmet medical need of NASH, scarcity of the permanent treatment of the disease, increasing prevalence of obesity, and high demand for safe and effective medication. The regulatory bodies are supporting the NASH market by providing designations and funding for speeding up the drug development process. In March 2015, obeticholic acid, an investigational Phase III clinical trial drug candidate of Intercept Pharmaceuticals Inc., received breakthrough therapy designation from the U.S. Food and Drug Administration for the treatment of patients with NASH.

Request to Get the Sample Report at: https://www.psmarketresearch.com/market-analysis/nash-therapeutics-market/report-sample

Geographically, North America is expected to be the largest market for NASH therapeutics owing to the large number of research and development activities, high healthcare expenditure and high incidence of obesity. The U.S. contributed largest revenue to the North American market and it is expected to remain the largest market globally, during the forecast period.

Full Explore Report: https://www.psmarketresearch.com/market-analysis/nash-therapeutics-market

Some of the key players operating in the global NASH therapeutics market are Genfit SA, Gilead Sciences, Inc., Novo Nordisk A/S, Intercept Pharmaceuticals, Inc., Enzo Biochem, Inc., Raptor Pharmaceutical Corp., Conatus Pharmaceuticals Inc., Zydus Cadila Healthcare Limited., Novartis AG, and Shire plc.

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-Free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Growing Industry of Nonalcoholic Steatohepatitis Therapeutics Market - Growth and Demand Forecast to 2023 here

News-ID: 1010788 • Views:

More Releases from P&S Market Research - Healthcare

Advanced Wound Care Market Overview, Share, Growth Drivers and Future Analysis
Advanced Wound Care Market Overview, Share, Growth Drivers and Future Analysis
The advanced wound care market is growing due to increasing geriatric population and increasing awareness about these products combined with its increasing adoption. Increasing incidences cases of obesity and diabetes are also leading to increased demand for advanced wound care product. Among the different types of advanced wound care, the advanced wound dressing segment is expected to witness the fastest growth during the forecast period. Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/advanced-wound-care-market/report-sample Advanced wound
Blood Processing Devices and Consumables Market Competitive Insights, Significant Futuristic Trends And Opportunities 2022
Blood Processing Devices and Consumables Market Competitive Insights, Significan …
Increasing infections and related diseases due to blood transfusion and blood donation are some of the major concerns in healthcare arena. Infectious diseases through blood transfusions occur due to the presence of microorganism, such as bacteria, virus and others parasites, in blood of donors which reach to receivers and infect their blood. Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/blood-processing-devices-and-consumables-market/report-sample Hepatitis and Acquired Immunodeficiency Syndrome (AIDS) are some of the major infectious diseases
Latin America Scar Treatment Market Analysis Report | Growth and Demand Forecast, 2013-2023
Latin America Scar Treatment Market Analysis Report | Growth and Demand Forecast …
The Latin America (LATAM) scar treatment market size was valued at $677.2 million in 2016, which is expected to attain $1,225.0 billion by 2023, growing at a CAGR of 8.9% during the forecast period (2017-2023). Topical scar treatment held the largest share of the market in 2016, ahead of surface, laser, injectable, and invasive surgical treatments. Scar treatment for keloid & hypertrophic scar is expected to witness the highest growth
Asia-Pacific Scar Treatment Market by Type of Treatment, Scars, End User | Global Research Report, 2013-2023
Asia-Pacific Scar Treatment Market by Type of Treatment, Scars, End User | Globa …
The Asia-Pacific scar treatment market size was valued at $3.6 billion in 2016, which is forecasted to reach $7.8 billion by 2023, growing at a CAGR of 11.6% during the 2017-2023. Access Detailed Report Summary@ https://www.psmarketresearch.com/market-analysis/asia-pacific-scar-treatment-market Among the various types of scar treatments, topical scar treatment is expected to lead the scar treatment market in the region, followed by surface, laser, injectable, and invasive surgical treatment. Increasing focus on personal well-being,

All 5 Releases


More Releases for NASH

NASH Market Insight and Landscape report
Report Snapshot: NASH is one of the furthermost causes of liver disease worldwide and will probably emerge as the leading cause of end-stage liver disease in the coming years, with the disease affecting both adults and children. The epidemiology and demographic characteristics of NASH vary across different country level. Furthermore, individuals with NAFLD have a high frequency of metabolic comorbidities and could place a growing strain on health-care systems from their
IQ4I Research published “Non-alcoholic steatohepataitis (NASH) Pipeline Analys …
“Non-alcoholic steatohepataitis (NASH) Pipeline Analysis” gives comprehensive insights on the various drugs being developed for the treatment of NASH. The report covers all the drugs that are in various phases of development (Discovery, Preclinical & Clinical). The pipeline focuses on novel pharmacologic drugs & regenerative medicines covering small molecules, antibodies, stem cell therapies, recombinant proteins and RNA-based therapeutics, but excludes symptom relief drugs, generic combinations and supplemental drugs. The report
Growing Prevalence of NASH to Increase Adoption of Therapeutics
"The Report OpportunityAnalyzer: NASH - Opportunity Analysis and Forecasts to 2026 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" MarketResearchReports.biz has itemized the addition of a new market research report to its report repository. The research publication is titled, “Opportunity Analyzer: NASH - Opportunity Analysis and Forecasts to 2026.” The statistical surveying study is a watchful inspection of the general market
OpportunityAnalyzer: NASH - Opportunity Analysis and Forecasts to 2026
First described in 1980, nonalcoholic steatohepatitis (NASH) (ICD-10-CM = K75.81) is a condition that develops as a subgroup of nonalcoholic fatty liver disease (NAFLD) when excessive fat buildup is accompanied by liver cell injury and inflammation. NAFLD is defined by excessive fat accumulation in the form of triglycerides (steatosis) in the liver. Progression of this condition to NASH dramatically increases the risk of cirrhosis, liver failure, and hepatocellular carcinoma, and
04-07-2017 | Arts & Culture
Memphia PR
Nash releases debut EP 'She Don't Know'
London-based singer/songwriter Nash has released his debut EP She Don’t Know. Recorded at the legendary RAK Studios, She Don’t Know has the feel of 60s rock but with a modern twist, leaving the listener hooked throughout and wanting to come back for another listen. She Don’t Know’s leading single CK is an infectious number which is sure to be a hit for 2017. Listening to the Beatles and Jack White growing
Nash Technologies at GITEX/GULFCOMMS 2010
Harvey Nash subsidiary presents expert services to telecom operators in the Middle East, Africa and South Asia region Nürnberg/Germany, 10th September 2010 – For the first time Nash Technologies will be present at GITEX/GULFCOMMS, the largest international trade event for mobile, fixed, IP and satellite communications for the Middle East, Africa and South Asia region, in Dubai from 17th to 21st October 2010 offering its telecom expert services. Nash Technologies will